Search research articles
Contact Us
Filters
Showing results (141-150 of 193) with videos related to
Page
of 20
Sort By:
Journal of Neuroengineering and Rehabilitation
|
May 18, 2025
The Neuromusculoskeletal Modeling Pipeline: MATLAB-based model personalization and treatment optimization functionality for OpenSim
Claire V Hammond, Spencer T Williams, Marleny M Vega, et al.
Journal of Drugs in Dermatology : JDD
|
August 3, 2007
Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies
Mark Lebwohl, Alan Menter, Jonathan Weiss, et al.
Journal of Dermatological Science
|
January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study
Andrew Blauvelt, David M Pariser, Stephen Tyring, et al.
Archives of Dermatology
|
February 21, 2007
National Psoriasis Foundation clinical consensus on disease severity
David M Pariser, Jerry Bagel, Joel M Gelfand, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 31, 2016
Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
A Menter, K A Papp, M Gooderham, et al.
Journal of the American Academy of Dermatology
|
January 31, 2006
Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial
Diane Thiboutot, David M Pariser, Nancy Egan, et al.
The Journal of Clinical and Aesthetic Dermatology
|
January 3, 2022
Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices
Nathalie C Zeitouni, Neal Bhatia, Roger I Ceilley, et al.
American Journal of Clinical Dermatology
|
October 21, 2021
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
Linda Stein Gold, Hilary Baldwin, Leon H Kircik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 22, 2017
Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study
R Bissonnette, R Haydey, L A Rosoph, et al.
Journal of the American Academy of Dermatology
|
September 1, 1996
Guidelines of care for photoaging/photodamage. American Academy of Dermatology
L A Drake, S M Dinehart, E R Farmer, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 193) with videos related to
Sort By:
Page
of 20
Journal of Neuroengineering and Rehabilitation
|
May 18, 2025
The Neuromusculoskeletal Modeling Pipeline: MATLAB-based model personalization and treatment optimization functionality for OpenSim
Claire V Hammond, Spencer T Williams, Marleny M Vega, et al.
Journal of Drugs in Dermatology : JDD
|
August 3, 2007
Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies
Mark Lebwohl, Alan Menter, Jonathan Weiss, et al.
Journal of Dermatological Science
|
January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study
Andrew Blauvelt, David M Pariser, Stephen Tyring, et al.
Archives of Dermatology
|
February 21, 2007
National Psoriasis Foundation clinical consensus on disease severity
David M Pariser, Jerry Bagel, Joel M Gelfand, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 31, 2016
Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
A Menter, K A Papp, M Gooderham, et al.
Journal of the American Academy of Dermatology
|
January 31, 2006
Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial
Diane Thiboutot, David M Pariser, Nancy Egan, et al.
The Journal of Clinical and Aesthetic Dermatology
|
January 3, 2022
Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices
Nathalie C Zeitouni, Neal Bhatia, Roger I Ceilley, et al.
American Journal of Clinical Dermatology
|
October 21, 2021
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
Linda Stein Gold, Hilary Baldwin, Leon H Kircik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 22, 2017
Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study
R Bissonnette, R Haydey, L A Rosoph, et al.
Journal of the American Academy of Dermatology
|
September 1, 1996
Guidelines of care for photoaging/photodamage. American Academy of Dermatology
L A Drake, S M Dinehart, E R Farmer, et al.
Page
of 20